An update on the management of urinary tract infections in the era of antimicrobial resistance
MS Bader, M Loeb, AA Brooks - Postgraduate medicine, 2017 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …
The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection
JD Lutgring, BM Limbago - Journal of clinical microbiology, 2016 - Am Soc Microbiol
The emergence and spread of carbapenemase-producing carbapenem-resistant
Enterobacteriaceae (CP-CRE) are a significant clinical and public health concern. Reliable …
Enterobacteriaceae (CP-CRE) are a significant clinical and public health concern. Reliable …
[HTML][HTML] Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections
Chronic Pseudomonas aeruginosa infections evade antibiotic therapy and are associated
with mortality in cystic fibrosis (CF) patients. We find that in vitro resistance evolution of P …
with mortality in cystic fibrosis (CF) patients. We find that in vitro resistance evolution of P …
Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician
N Martis, S Leroy, V Blanc - Journal of Infection, 2014 - Elsevier
Antimicrobial resistance to Pseudomonas aeruginosa is on the rise. In the absence of new
anti-pseudomonal drugs, clinicians have had to resort to older antimicrobials such as colistin …
anti-pseudomonal drugs, clinicians have had to resort to older antimicrobials such as colistin …
Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation
SH MacVane, JL Kuti, DP Nicolau - International journal of antimicrobial …, 2014 - Elsevier
Given the sparse antibiotic pipeline and the increasing prevalence of resistant organisms,
efforts should be made to optimise the pharmacodynamic exposure of currently available …
efforts should be made to optimise the pharmacodynamic exposure of currently available …
[HTML][HTML] Treatment of bloodstream infections in ICUs
JF Timsit, JF Soubirou, G Voiriot, S Chemam… - BMC infectious …, 2014 - Springer
Bloodstream infections (BSIs) are frequent in ICU and is a prognostic factor of severe sepsis.
Community acquired BSIs usually due to susceptible bacteria should be clearly …
Community acquired BSIs usually due to susceptible bacteria should be clearly …
Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India
LEB Nabarro, C Shankar, AK Pragasam… - The Pediatric …, 2017 - journals.lww.com
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are an increasing cause of
nosocomial infection in hospitalized children worldwide. Few studies have investigated risk …
nosocomial infection in hospitalized children worldwide. Few studies have investigated risk …
Continuous and prolonged intravenous β-lactam dosing: implications for the clinical laboratory
M Grupper, JL Kuti, DP Nicolau - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Beta-lactam antibiotics serve as a cornerstone in the management of bacterial infections
because of their wide spectrum of activity and low toxicity. Since resistance rates among …
because of their wide spectrum of activity and low toxicity. Since resistance rates among …
Defining clinical exposures of cefepime for gram-negative bloodstream infections that are associated with improved survival
NJ Rhodes, JL Kuti, DP Nicolau… - Antimicrobial agents …, 2016 - Am Soc Microbiol
The percentage of time that free drug concentrations remain above the MIC (f T> MIC) that is
necessary to prevent mortality among cefepime-treated patients with Gram-negative …
necessary to prevent mortality among cefepime-treated patients with Gram-negative …
Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs
TS Patel, JL Nagel - Journal of clinical microbiology, 2015 - Am Soc Microbiol
ABSTRACT The Clinical and Laboratory Standards Institute (CLSI) lowered the MIC
breakpoints for meropenem and imipenem from 4 mg/liter to 1 mg/liter for …
breakpoints for meropenem and imipenem from 4 mg/liter to 1 mg/liter for …